WO2026130493 - METHOD FOR TREATING ALLERGIC RHINITIS BY ANTI-IL-4Rα ANTIBODY
National phase entry is expected:
Publication Number
WO/2026/130493
Publication Date
25.06.2026
International Application No.
PCT/CN2025/143721
International Filing Date
19.12.2025
Title **
[English]
METHOD FOR TREATING ALLERGIC RHINITIS BY ANTI-IL-4Rα ANTIBODY
[French]
MÉTHODE DE TRAITEMENT DE LA RHINITE ALLERGIQUE PAR UN ANTICORPS ANTI-IL-4Rα
[Chinese]
抗IL-4Rα抗体治疗过敏性鼻炎的方法
Applicants **
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors
YU, Ding
ZHANG, Xiquan
WANG, Xunqiang
YANG, Anqi
ZHANG, Qin
Priority Data
202411899227.4
20.12.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1847 | |
| EPO | Filing, Examination, Granting | 12005 | |
| Japan | Filing, Examination, Granting | 2218 | |
| South Korea | Filing, Examination, Granting | 2197 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
23,607
Contact Us
Abstract[English]
Provided is a method for treating allergic rhinitis by an anti-IL-4Rα antibody, which comprises administering the anti-IL-4Rα antibody or an antigen-binding fragment thereof to a subject, wherein the allergic rhinitis is preferably seasonal allergic rhinitis.[French]
L'invention concerne une méthode de traitement de la rhinite allergique par un anticorps anti-IL-4Rα, comprenant l'administration de l'anticorps anti-IL-4Rα ou d'un fragment de liaison à l'antigène de celui-ci à un sujet, la rhinite allergique étant de préférence une rhinite allergique saisonnière.[Chinese]
提供了抗IL-4Rα抗体治疗过敏性鼻炎的方法，包括向受试者施用抗IL-4Rα抗体或其抗原结合片段，其中过敏性鼻炎优选为季节性过敏性鼻炎。